Recombinant adenovirus vectors are powerful tools for inducing de novo gene expression in vivo. Here we have exploited them to study the specificity of CD4/CD8 lineage commitment during thymocyte positive selection, transferring MHC class II genes directly into thymi of mice deficient in both class I and II molecules. Expression of class II molecules was induced on cortical stroma, provoking the selection of a large population of mature CD4 ⍣ CD8 -cells, as expected, but also of a significant number of CD4 -CD8 ⍣ cells. The latter constituted a diverse population, containing both immature precursors and, though less frequent, cells that were mature according to several criteria. CD4 -CD8 ⍣ cells appeared with the same kinetics as their CD4 ⍣ CD8 -counterparts, but tended to be more prevalent at early times or when thymocyte reconstitution was only modest. These observations, derived from a dynamic selection system, indicate that CD4/CD8 lineage commitment is not irredeemably linked to the class of MHC molecule driving positive selection, a conclusion most compatible with selective models of commitment.
Introduction
The peripheral T lymphocyte repertoire of mature animals consists of two main populations, which share expression of the αβ TCR and can be differentiated by the surface display of either the CD4 or CD8 co-receptor molecule. The precursors of these peripheral populations undergo a highly regulated program of differentiation in the thymus. Chromosome rearrangement occurs at defined stages, resulting in the juxtaposition of germline TCR gene segments, first at the β locus, then at the α, to generate a functional gene that encodes the clonotypic receptor characteristic of each T cell clone, and defining its antigen specificity. At this stage, the thymocytes express both the CD4 and CD8 co-receptors. Double-positive (DP) cells are subjected to a selection process keyed on the specificity of their receptors (1) . Cells expressing a TCR capable of recognizing MHC molecules complexed with self-peptides on cortical epithelial cells are positively selected and finish the maturation process, shutting off synthesis of one of the co-receptor molecules to become either CD4 or CD8 single-positive (CD4-or CD8-SP) cells. However, cells expressing a receptor with too high an affinity for self-MHC-peptide ligands are eliminated by negative Correspondence to: C. Benoist Transmitting editor: T. Sasazuki Received 27 January 1999, accepted 31 May 1999 selection. The net result is a repertoire purged of useless cells unable to recognize foreign antigens presented by the animal's MHC molecules and of harmful cells reactive to selfantigens presented by self-MHC molecules. The requirements for positive selection have been thoroughly analyzed over the past decade using genetically manipulated mice. Experiments involving TCR transgenic animals have demonstrated that DP thymocytes expressing class I-reactive TCR are generally selected to become CD8 ϩ cells (2-4), while those displaying class II-reactive receptors differentiate into CD4 ϩ cells (5, 6) . Elimination of MHC class I or class II molecules by homologous recombination has shown that they are essential for the maturation of endstage CD4-or CD8-SP respectively (7) (8) (9) (10) . Thus, the positive selection process seems to coincide with lineage commitment, the specificity of the TCR for a class of MHC molecule matching the co-receptor expressed by the mature cell. How this match is achieved, and the nature of the signals that direct commitment towards the CD4 or CD8 lineage, remain unclear. It has been debated whether lineage choice is primarily instructive (directed from the start by the recognition of MHC class during TCR-MHC interaction) or selective (initial commitment following other cues and confirmed only secondarily after shut-off of one co-receptor), or some combination of the two (for review and references, see 11).
Much of the debate has centered on the existence of receptor/co-receptor mismatched cells (e.g. CD4 ϩ CD8 -cells expressing a TCR with affinity for MHC class I molecules), either as transitional intermediates or as fully mature lymphocytes. Such cells should not exist according to the instructive model, but are clearly predicted by the selective model. By now, the weight of evidence indicates that 'mismatched' transitional intermediates do exist in thymi of TCR transgenic or MHC-deficient mice (for review, see 11); mismatched mature cells have also been observed in some cases. In particular, examples of TCR transgenic mice expressing class II-restricted TCR and generating significant numbers of CD8-SP in a class II-dependent fashion have been described (12, 13) . This non-standard commitment was enhanced when co-receptor deficiencies were introduced (13) and full maturation of the class II-restricted CD8 ϩ T cells was enhanced in the presence of class I molecules, but not in an allele-specific fashion.
It has been argued that the latter evidence is not generalizable and merely represents transgenic phenomenology peculiar to these receptors. Indeed, it has repeatedly been asserted that commitment to the CD8 lineage requires an instructive signal that can only be delivered by MHC class I molecules (14) (15) (16) . Thus, it would be of interest to know whether the ability of class II molecules to mediate selection of CD8-SP extends to a broader repertoire of TCR specificities. In a previous study of thymocyte selection, we used an adenovirus-based gene delivery system to introduce class II molecules into the thymus of animals deficient in both classes of MHC molecules (17) . As expected, CD4-SP cells were efficiently selected and exported to the periphery. In the course of these experiments, we also noticed the appearance of a significant population of CD8-SP cells. Here, we focus on the generation and phenotype of these class II-elicited CD8-SP cells, and discuss the implications of our findings for models of CD4/CD8 lineage commitment.
Methods

Mice
Mutant animals were β 2 -microglobulin (β2m)-deficient (I°) (10) or MHC class I/II double-deficient (I°II°) (18) . All mutant strains were on a mixed C57Bl/6 (B6)ϫ129 genetic background. All mice were bred under specific pathogen-free conditions, and housed and handled under EEC guidelines. Virus injections and subsequent animal husbandry were performed under Ministè re de l'Agriculture guidelines (Agré ment B67900).
Recombinant viruses and intrathymic (i.t.) injections
The recombinant viruses have been described (17) . Briefly, they carry a cDNA segment encoding an MHC class II molecule under the control of the E α promoter, placed in lieu of the deleted E1A region of the adenovirus 5 mutant dl234. Viruses encoding either the A β b or E α k chains were used-as they yielded identical results, they are often not distinguished in the figures. Viruses were grown as large stocks in 293 cells, and were purified and concentrated as described (17) . For every virus preparation, one aliquot was thawed to verify the genomic structure of the amplified virus and to determined its titer. The i.t. injections of 4-to 6-week-old mice were performed as described (17), each thymic lobe receiving 10 µl of either control or recombinant virus, corresponding tõ 3ϫ10 8 infectious particles.
Flow cytometry
Single-cell thymocyte suspensions were stained with the following mAb: KT3 (anti-CD3ε), H57-597 (anti-TCRαβ), IM-7 (anti-CD44), anti-CD-69 (PharMingen, San Diego, CA) and anti-CD8 (Caltag, Paris, France) (17) . Flow cytometry was performed on a Coulter Elite instrument with 488 nm argon and 590 nm dye laser excitation, fitted with four-decade logarithmic amplifiers, and data were stored as list mode for analysis. Analysis of list-mode files was performed on Elite software (Coulter, Margency, France), generating contour pseudo-dot plots. Live cells were gated on forward versus side scatter profiles.
Results
We have shown previously that i.t. injection of adenovirus vectors encoding MHC class II molecules (Ad-cII) into MHCdeficient mice (I°II°) induced significant expression of class II molecules on the surface of thymic epithelial cells (17) . The vectors encoded either a functional A β chain, complementing an engineered defect in the MHC-deficient mouse strain, or an E α chain, complementing a naturally occurring mutation. As anticipated, the restoration of class II molecule expression induced the selection and maturation of a significant CD4-SP population (17) (Fig. 1 ). Unexpectedly, a small but distinct and reproducible increase in the number of CD8-SP cells could also be detected in the cytofluorimetic profiles of thymocytes from Ad-cII-injected mice (Fig. 1C) ; such cells were absent from unmanipulated I°II°animals (not shown) and from those injected with the dl324 control virus (Fig. 1B) . The newly generated CD8-SP thymocytes were best visualized when the analysis was focused on cells displaying high surface levels of CD3 (Fig. 1A-C , right panels). Because there is significant variation in the efficiency of i.t. gene delivery by adenovirus vectors (17) , the number of CD8-SP recovered after transduction of class II genes fluctuated significantly from mouse to mouse; however, these cells were consistently observed whenever the recovery of CD4-SP signalled efficient infection (see below). E α -and A β -transducing viruses were equally effective at promoting the selection of CD8-SP, and therefore we have pooled results from the two types of injections. The CD4 -8 ϩ thymocytes in Ad-cII-injected I°II°mice were mature by several criteria. First, four-color cytofluorimetry, staining with an anti-αβTCR mAb and peanut agglutinin (PNA) in addition to anti-CD4 and anti-CD8 reagents, (Fig. 1, lower  panels) showed that the newly generated CD8-SP cells had a phenotype typical of mature cells: high expression of the TCR, low levels of PNAr. These cells also expressed mature levels of heat stable antigen (not shown). Cells with this phenotype were essentially absent from I°II°animals injected with control virus. A second approach to document the maturation of the CD4 -CD8 ϩ thymocytes in Ad-cII-injected mice was to evaluate their sensitivity to glucocorticoids, which eliminate immature thymocytes but tend to spare the mature populations (19) . While virtually no CD8-SP cells remained in the thymus of a control virus-injected I°II°mouse after dexamethasone treatment, a clear population resisted in animals injected with Ad-cII,~10% of the numbers found in the wild-type control; as expected, these cells display high levels of TCR (Fig. 2) . Thus, the newly generated CD8-SP cells appeared to be bona fide mature thymocytes. Figure 3(A) shows the time-course of appearance of mature thymocytes after i.t. injection of Ad-cII. As previously reported (17), CD4-SP cells began to accumulate at day 9-10 postinjection, reflecting the time required for virus entry and decapsidation, transcription of the viral genome, translation and transport of the class II gene products, and transition of the newly selected DP cells into the SP compartment. The timing of appearance of CD8-SP cells was very similar, significant numbers again first appearing after day 8 postinjection; if anything, accumulation was slightly accelerated vis-à -vis CD4-SP. By these criteria, the CD8-SP seemed to be elicited directly by class II molecules and not indirectly, somehow in response to the sudden appearance of CD4-SP.
Interestingly, there seemed to be a cap on the total number of CD4 -CD8 ϩ cells selected after Ad-cII injection. This point is illustrated in Fig. 3(B) , a plot of the relative reconstitution of the CD4-and CD8-SP populations in individual mice. As noted above, the efficacy of adenovirus-mediated gene transfer after i.t. injection is quite variable from mouse to mouse: the number of CD4-SP cells ranged from only slightly above background to comparable with those of wild-type ment was relatively better when that of the CD4-SP was only partial. Figure 3 (B) also shows that thymi of unmanipulated I°II ϩ mice host very few CD8-SP.
Thus, class II molecules transduced by adenoviral transfer into MHC-deficient thymi were capable of selecting and maintaining a population of mature CD4 -CD8 ϩ cells. Two observations suggested that this process was slightly peculiar, though. First, CD69 was under-expressed on these cells. In normal mice, this early activation marker is transiently displayed on most thymocytes engaged in positive selection, although CD4-SP cells tend to be more uniformly positive than their CD8 ϩ counterparts (20, 21) . In the virally transduced thymi, the CD8-SP cells expressed very little CD69 (Fig. 4A) , even though CD4-SP from the same thymi showed normal levels (data not shown). Second, the Ad-cII-elicited CD8-SP population was enriched for early intermediates over fully mature cells. This peculiarity is visible in the analysis of dexamethasone-resistant thymocytes of Fig. 2 , but is perhaps better appreciated by comparing CD4 levels in Fig. 4(B) : in wild-type mice, most of the CD8-SP had completely downregulated CD4 expression; in contrast, in Ad-cII-injected I°II°m ice, there was a higher proportion of cells with residual levels of CD4. 
Discussion
Intrathymic injection of an MHC class II gene into MHCdeficient mice provoked selection of a substantial cohort of CD8-SP thymocytes, in addition to the expected CD4-SP cells. The CD8-SP resulted from positive selection, as indicated by their TCR hi PNA lo dexamethasone-resistant phenotype, their kinetics of appearance after transduction of MHC class II genes and their absence after injection of control virus. One might raise the caveat that these CD8-SP might not be selected by class II molecules themselves but by stabilization of unstable MHC class I molecules by class II-derived peptides; this seems unlikely since there is no precedent of an influence of class II on class I maturation or stability, and since both E α -and A β -carrying vectors have the same effect. It might have been argued that i.t. injection of adenovirus particles somehow leads to the appearance of CD8-SP thymocytes when MHC class II molecules are present, through some non-specific response to viral particles or the cytokines they induce. This possibility was ruled out by injecting control or MHC class II-expressing viruses into thymi of I°II ϩ mice: no CD8-SP appeared under such circumstances (data not shown).
As previously reported (9, 10) , such a population of CD8-SP thymocytes is not found (or in nowhere near the same frequencies) in I°II ϩ mice, which have the same complement of MHC genes as Ad-cII-injected animals, and this point is brought home by the direct comparison in Fig. 3(B) . The difference probably lies in the timing of class II molecule expression in the two cases and in the ensuing competition between different thymocyte populations. In the I°II ϩ mice, class II molecules are expressed from fetal life onwards and the compartment of mature thymocytes is filled with abundant CD4-SP. In contrast, class II molecules appear suddenly in Ad-cII-injected I°II°animals and the first wave of selected cells finds itself in an empty compartment with no immediate competitors. Class II-restricted CD8-SP are thus free to accumulate, at least until CD4-SP fill the available space. It is easy to understand why class II-restricted CD8-SP cells, whose selection may not be the most robust, would be visible after a punctual turn-on of MHC class II molecules but not in a steady-state situation. In addition, there is some evidence for this interpretation in the ceiling reached by CD8-SP even after the best i.t. transfers of virus (Fig. 3B) .
Competition for positive selection has been described (22, 23) . Not all cells potentially able to be positively selected actually do, as seen in mixed reconstitution experiments with transgenic or wild-type precursors restricted by the same MHC molecule (22, 23) , perhaps due to a limiting number of niches capable of supporting selection of a particular lineage (24) . It is interesting that the competition hypothesized here would take place after the initial TCR-MHC interaction: the initial commitment and selection events would generate both receptor/co-receptor-matched and -mismatched intermediates, but competition would modulate the survival and progression of maturing populations. CD4-SP would have an advantage over class II-restricted CD8-SP, most likely because they maintain CD4 expression at the cell surface, allowing optimal signals from co-engaged TCR and coreceptor. These optimal signals would make for winners in the competition for space in the thymic niches.
This demonstration of class II-mediated selection of CD8-SP thymocytes extends reports of class II-restricted CD8-SP in TCR transgenic systems (12, 13) . It indicates that these prior results were not due to quirks of the TCRs under study, but can be generalized to broad, randomly generated, repertoires. Interestingly, and as in the TCR transgenic systems (12,13), we found very few corresponding CD4 -CD8 ϩ lymphocytes in the peripheral lymphoid organs of the reconstituted mice; even in the best cases, mice with sizeable CD8-SP thymic populations only had rare peripheral cells, barely and inconsistently above the background of cells in unmanipulated I°II°m ice. The most straightforward explanation for this paradox may lie in recent observations that the survival of naive CD8 ϩ lymphocytes requires continued engagement by MHC molecules involved in their selection (25) . The class IIrestricted CD8 ϩ lymphocytes selected after thymic class II gene transfer cannot survive in the periphery because they cannot find class II molecules there, while the rare CD8-SPs already present in I°II°lymph nodes without manipulation are probably stabilized by the self-molecules that selected them (non-classical class I, residual D b ?).
These observations are not consistent with models of thymocyte lineage commitment that contend that commitment to the CD8 lineage requires instructive signals that can only be delivered through class I molecules (14) (15) (16) : the CD8-SP observed here in substantial numbers were selected without intervention of class I molecules, in keeping with the recent demonstration that CD8 lineage commitment can be induced in vitro without class I (26) . These observations are consistent with a model in which initial lineage commitment is chosen independently of the class of MHC molecule, but depends on the affinity/kinetic characteristics of the signal received through the TCR, subsequent survival of the cells requiring that this choice provide a match between the remaining coreceptor and the specificity of the receptor (for review, see 11).
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